Profile of Serum Institute
Biocon is India’s largest biotech firm, right? Wrong! According to this profile in Business Today, Pune-based Serum Institute of India, has the crown with revenues of Rs 987 crore in…
Biocon is India’s largest biotech firm, right? Wrong! According to this profile in Business Today, Pune-based Serum Institute of India, has the crown with revenues of Rs 987 crore in…
Edited Extracts From Press Release: Mukta Arts Limited, a BSE-listed Media & Entertainment company has acquired a controlling stake in Chennai-based mobile content and application company Coruscant Tec. Following this…
Extracts from Press Release: India’s fourth largest securities brokerage house, SMC Group (“SMC”) has announced today that it had entered into joint venture agreements (JV) with Sanlam Investments, the investment…
Nadathur S Raghavan Centre for Entrepreneurial Learning (NSRCEL) at IIM-Bangalore is organizing two day workshops for entrepreneurs. The first – on Sep. 29 & 30 – will focus on Business…
An article in Business Today examines the debate around one of corporate India’s favorite funding instruments – foreign currency convertible bonds (FCCBs) – at a time when the stock prices…
The Onion has a hilarious “news item” on how recession-plagued Americans are demanding a New Bubble to invest in. Perhaps the new bubble could have something to do with watching…
Angel investor Paul Kedrosky has sparked off a discussion on where-in -the-world an unencumbered 22-year-old American graduate would like to for an exciting first job. You want to be part…
Business Standard has a feature on the outdoor advertising / Out of Home (OOH) media business. City development in India is riding on the back of advertising support from OOH…
Business Today has a profile of Anand Jain, promoter of the infrastructure-focused Jai Corporation and the real estate-focused Urban Infrastructure Fund. That Jain is (Mukesh) Ambani’s lieutenant is quite clear,…
Businessworld has an analysis of Infosys’ $750 million acquisition of UK-listed Axon. The timing of the acquisition is also attracting attention. “Why acquire Axon now?” asks Peter Schumacher, CEO of…